|
Groups
|
CD3+ CD4+ CD8− (%)
|
CD3+ CD8+ CD4− (%)
|
|---|
|
PBS
|
15.31 ± 0.12
|
7.35 ± 0.18
|
|
alum
|
17.34 ± 0.34
|
9.62 ± 0.29
|
|
MPLA
|
17.92 ± 0.25
|
9.08 ± 0.24
|
|
alum-MPLA
|
18.49 ± 0.19
|
10.13 ± 0.30
|
|
pEGFP- toxofilin
|
20.17 ± 0.53*
|
12.48 ± 0.43*
|
|
alum-toxofilin
|
21.37 ± 0.76*
|
12.98 ± 0.45*
|
|
MPLA-toxofilin
|
27.46 ± 0.97*#
|
17.39 ± 0.98*#
|
|
alum-MPLA-toxofiln
|
32.38 ± 1.19*#
|
20.68 ± 1.37*#
|
-
aSplenocytes from 3 mice per group at the fourth week after the final immunization
-
*Compared with PBS, alum, MPLA, alum-MPLA. P <0.05
-
#Compared with alum-toxofilin or pEGFP-toxofilin groups, P <0.05
- Results are presented as means ± SD of three replicate determinations
